Scientists With M.S. Degrees Find Good Career Prospects In Industry

Prospects In Industry For the scientist who left graduate school holding a master's degree, career prospects in industry look good, according to those involved in corporate hiring. A primary reason for this, they note, is that industry openings at the master's level aren't suffering from a mismatch of supply and demand. Ph.D.'s, on the other hand, are graduating faster than university faculty positions are opening up, and the business world is not picking up the doctoral-level researchers left

Written byLee Katterman
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Prospects In Industry For the scientist who left graduate school holding a master's degree, career prospects in industry look good, according to those involved in corporate hiring. A primary reason for this, they note, is that industry openings at the master's level aren't suffering from a mismatch of supply and demand. Ph.D.'s, on the other hand, are graduating faster than university faculty positions are opening up, and the business world is not picking up the doctoral-level researchers left behind.

'LOTS OF JOBS': Placement officer Catherine Connor says that in many cases, opportunities are better for master's scientists than for Ph.D.'s "At the master's level, there are lots of jobs. The opportunities are better than for Ph.D.'s," says Catherine Connor, director of placement for the Biotechnology Center at the University of Illinois, Urbana-Champaign. "Master's students are being hired. I don't want to say [they are being hired] in preference over Ph.D.'s, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies